| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.051 | 0.8 |